Azenta, Inc. (AZTA)

Azenta, Inc. is trading at $39.06, down 5.36% on the session. The 50 day average sits at $34.97 and the 200 day at $28.37, which puts the stock in a uptrend. RSI is at 57.4, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $34.93 with resistance near $46.41, so that band frames the current range. Average daily movement is roughly $2.13, or about 5.5% of the share price, which is what any stop placement has to allow for. The overall health score of 79 out of 100 combines a trend score of 100, momentum of 87 and a risk score of 36.

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, gene synthesis, and related services. The company has a strategic partnership with Frontier Space Ltd to conduct scientific experiments in space. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.